Medical News

RSS

First filing for zoledronic acid in metabolic bone disease

One 15-minute infusion of the intravenous bisphosphonate zolendronic acid more rapidly reduced the biochemical markers of bone turnover in patients with Paget's disease than was seen in a head-to-head comparison with the oral treatment risedronate (95% vs. 75% response rate).

17 May 2004

Scientists move closer toward treatment for degenerative diseases

Scientists at McGill University's Faculty of Medicine have discovered a key step that will provide new targets for treatments of many degenerative diseases such as Alzheimer's, Cystic Fibrosis and Diabetes.

17 May 2004

Howard Hughes Medical Institute is awarding $49.7 million in science grants

Colleges face a number of tough challenges in teaching science today. New fields that blur the lines between disciplines are emerging, and biologists, chemists, physicists and mathematicians are forging interdisciplinary collaborations. Scientists trained to be outstanding researchers need to learn to be outstanding teachers. More minorities must be encouraged to pursue scientific careers.

17 May 2004

FDA to determine health significance of low furan levels in foods

The Food and Drug Administration today announced that it will embark on a thorough scientific assessment of the health significance of very low levels of furan -- a chemical that is produced through the heating process - in certain foods. FDA has initiated this process through a notice on display today at the Office of the Federal Register.

17 May 2004

FDA today alerted consumers not to purchase or use a recalled lot of DU brand nasal decongestant spray

FDA today alerted consumers not to purchase or use a recalled lot of DU brand nasal decongestant spray (distributed by Drugs Unlimited, of Puerto Rico) because it may be contaminated with Burkholderia cepacia – a bacterium that could cause serious, potentially life-threatening infections in some patients. Individuals with compromised immune systems, especially those with cystic fibrosis, could be at risk.

17 May 2004

$1.4 million to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier

The Cleveland Clinic has been awarded a four-year, $1.4 million grant from the National Institutes of Health to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier. Researchers hope to use their findings to develop new methods to limit the damage caused by such events.

17 May 2004

Interventional radiologists now are able to treat using minimally invasive procedures

Interventional radiologists at Temple University Hospital now are able to treat many patients with minimally invasive procedures not available only a few years ago. “Conditions that used to require extensive surgery now take an hour or less, and patients leave with a bandaid and walk home,” says Gary Cohen, M.D., Section Chief of Interventional Radiology and Vice Chairman of Radiology. “How can you beat that?”

17 May 2004

Research into sleeping disorder drug may help multiple sclerosis patients

A University of Nottingham academic is leading a research project looking at whether a drug produced for a sleeping disorder could improve the quality of life for thousands of multiple sclerosis patients.

17 May 2004

British cancer charities call for improved lung cancer care

Today, MPs are being urged to support cancer charities' call for the provision of modern equipment vital to the treatment of people living with lung cancer, six months after the Government first promised to produce a national framework.

17 May 2004

Steps to tackle bed-blocking have led to a big reduction in delayed discharges

Health Secretary John Reid said that the 4,000 beds that have been freed up since the ‘Cash for Change’ programme was introduced in 2001 was equivalent to adding eight extra hospitals to the NHS. The scheme provided £300m to local councils to ensure that people leaving hospital would get the care they needed.

17 May 2004

New joint UK-Slovak health collaboration

A new joint UK-Slovak programme to boost collaboration into a range of medical conditions was announced by Health Minister John Huttontoday.Mr Hutton signed a joint agreement between the UK and Slovak Republic covering medicine and public health.

17 May 2004

Study examines impact of cochlear implants

Cochlear implants are small electronic devices that are surgically implanted in the ear, aiding those deaf people not helped by traditional hearing aids. Approximately 90 percent of parents who have deaf children are not deaf, and generally have had little, if any, experience with deaf persons or understanding of deafness. However, perceptions may be changing, partially due to new research on the implants, the article states.

17 May 2004

Discovery of the gene for Cornelia de Lange syndrome

An international team of researchers has discovered the gene for Cornelia de Lange syndrome, a disabling, multisystem genetic disease that affects an estimated one in 10,000 children. The finding is expected to lead to a genetic test, enabling rapid and definitive diagnosis of the syndrome, as well as prenatal testing for families who already have one child with the disease.

17 May 2004

The Australian Medical Association (WA) today slammed proposed changes to Workers Compensation legislation

"This arrogant and offensive legislation will mean the Government will have the power to tell injured workers how many times they can see their doctor and what treatment they can receive," AMA Workers Compensation spokesman Dr Richard Choong said.

17 May 2004

Statins should not be considered as a stand-alone wonder-drug in the fight against heart disease

Dr John Reid, the Health Secretary for the United Kingdom (UK), announced the reclassification of statins as ‘over the counter’ products in the UK, to be available to members of the public directly from pharmacists without the need for a prescription.

17 May 2004

IMPAX receives final FDA approval for generic version of Sinemet CR

IMPAX Laboratories, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted final approval to the Company's Abbreviated New Drug Application (ANDA) for Carbidopa/Levodopa Extended Release Tablets, its generic version of Sinemet(R) CR tablets.

17 May 2004

New website for oral cancer prevention and detection

Every year in the United Kingdom, approximately 3, 500 people are diagnosed with oral cancer. About half these people will die of the disease. On average, four people in the UK die every day from oral cancer.

17 May 2004

Pharmaceutical agreement involving novel obesity compound

Bristol-Myers Squibb Company and Solvay Pharmaceuticals today announced that the companies have entered into a worldwide agreement for the Solvay compound SLV319, which is currently in Phase I development with potential for use in treating obesity and other metabolic disorders.

17 May 2004

Managing large numbers of patients from mass casualty incidents

Today’s hospitals are challenged to become better prepared to manage large numbers of patients from mass casualty incidents (MCI), hazardous material incidents (HAZMAT), or in extreme cases, attacks using weapons of mass destruction (WMD).

17 May 2004

Vocational rehabilitation services helps people with traumatic brain injuries get back to work

More than 2 million people in the United States suffer traumatic brain injuries (TBI) each year, costing the nation nearly $1 billion in lost wages, increased government support and lost tax income in the first year alone. However, a University of Missouri-Columbia researcher has found that persons with TBI have a good chance of successfully returning to work if they receive vocational rehabilitation services.

17 May 2004